Cassava Sciences Misses Out On The Alzheimer’s Space Party (NASDAQ:SAVA)
Christa Boaz/E+ via Getty Images Wednesday, September 28, was a good day for many biotech stocks developing drugs for Alzheimer’s, as Biogen (BIIB) and Eisai (OTCPK:ESALY) reported success in a phase 3 study of lecanemab […]
